The Art and Science of Risk Management: A US Research-Based Industry Perspective

ISSN： 0114-5916

Source： Drug Safety, Vol.28, Iss.1, 2005-01, pp. : 1-18

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impact of the Clinical Trials Directive on the Research-Based Pharmaceutical Industry

By Moira Daniels

International Journal of Pharmaceutical Medicine, Vol. 18, Iss. 1, 2004-01 ,pp. : 5-8

Adis International

Access to resources Recommend Favorite

The Research-Based Pharmaceutical Industry and Society: What Is at Stake in the Future?

By Wndisch Karl

Journal of Pharmaceutical Marketing & Management, Vol. 16, Iss. 1, 2005-01 ,pp. : 21-40

Haworth Press

Access to resources Recommend Favorite

The Child Health Toolbox, a research-based, online tool for explaining performance measurement as it relates to children and adolescents in the US, is now available

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 306, 2001-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

CARCINOGENIC EFFECTS OF BENZENE—A STATUS UPDATE AND RESEARCH NEEDS TO IMPROVE RISK ASSESSMENT: U.S. EPA PERSPECTIVE

By Sonawane Babasaheb Bayliss David Valcovic Lawrence Chen Chao Rodan Bruce Farland William

Journal of Toxicology and Environmental Health, Vol. 61, Iss. 5-6, 2000-11 ,pp. : 471-472

Taylor & Francis Ltd

Access to resources Recommend Favorite

Isotretinoin risk management to be strengthened in the US

Reactions Weekly, Vol. 1, Iss. 1030, 2004-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite